NANOVI A/S: Financial statements 2014
CVR: 34889031
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
NANOVI A/S (CVR 34889031) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -2,738,413 and a net result of DKK -3,193,717 compared with DKK -1,851,144 the year before. Equity in the 2014 report amounted to DKK 1,494,975. The solvency ratio was 31.6%.
- Gross Profit
- DKK -2,738,413
- Profit/Loss
- DKK -3,193,717
- Equity
- DKK 1,494,975
- Total Assets
- DKK 4,732,035
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -2.7M | -3.2M | 1.5M | - |
| 2013 | - | -1.1M | -1.9M | 2.7M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of NANOVI A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of NANOVI A/S.
On September 4, 2014, the company changed its name from NANOVI RADIOTHERAPY ApS to NANOVI RADIOTHERAPY A/S.
NANOVI A/S has published its annual report for 2013. Gross profit came to DKK -1,142,278, and the net result was DKK -1,851,144.
As of May 22, 2014, Flemming Carl Thorup has joined the board of directors of NANOVI A/S.
As of May 22, 2014, Jon Ingi Benediktsson has joined the board of directors of NANOVI A/S.
As of May 22, 2014, Gordon McVie has joined the board of directors of NANOVI A/S.
About NANOVI A/S
NANOVI A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2012. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company was previously named NANOVI RADIOTHERAPY A/S and NANOVI RADIOTHERAPY ApS. The management consists of Michael Todd Galbus. The board consists of Percy Charwood Tomlinson Jr (chair), Jesper Boysen and Michael Todd Galbus. The company is owned by Sinmed Holding International B.V.. The company has 1 employee (2024). In 2025, the company reported revenue of DKK 90,321 and a net result of DKK -804,274 compared with DKK -612,100 the year before. Equity in the 2025 report amounted to DKK 560,746.